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Abstract—In this work, we analysed the effect of growth
factors on in vitro cell proliferation and collagens synthesis
by ﬁbroblasts cultured for 72 h on different substrates
(silicon sheet with or without 1% gelatin, and glass as
control surface) for ligament tissue engineering. A human
ﬁbroblast cell line (CRL-2703) was used. The synthesis of
type I and type III collagens were evaluated qualitatively and
quantitatively by RT-PCR and confocal microscopy, respec-
tively. Cell proliferation was evaluated by two methods: (1)
MTT assay (2) cell cycle analysis. It was found that PDGF-
AB stimulate the proliferation of ﬁbroblast cultured on
gelatin coated silicon sheet in dose dependant manner with a
maximum effect at 10 ng ml
)1. The exogenous TGF-b1
induced the expression of type I and type III collagens in a
dose and substrate-dependant manner. We deduce from this
work that biochemical conditions and substrates have an
important impact for optimisation of the tissue neo synthesis.
Keywords—Cell proliferation, Collagens synthesis, Fibro-
blasts, Growth factors, Substrates.
INTRODUCTION
Tissue engineering is a multidisciplinary ﬁeld at the
crossroads of biochemistry, mechanics, engineering
and materials science to develop substitutes for
replacing injured or diseased tissues.
14,15,25,48 For all
applications, it is necessary to take into account of
several points: cell source, growth factors, mechanical
forces, substrates, and the behaviour of the cells on the
substrate.
Substrates or scaﬀolds are deﬁned as the matrix that
provides a suitable environment for cell proliferation
and diﬀerentiation. Some scaﬀolds have been prepared
from natural and synthetic materials, such as collagen,
poly (glycolic acid) (PGA), and copolymers of L-lactic
acid and -caprolactone. It is necessary to improve the
physical and chemical nature of scaffold for the supe-
rior induction of tissue regeneration. However, the
chemical composition of the scaffold can have great
inﬂuence on its biocompatibility.
5,38 The source, solu-
bility, degree of cross linking, physical form of the
protein coating substrates, and the substrates itself can
inﬂuence the cell functions like proliferation and
metabolic activity.
5
Cells and materials are two essential components in
ligament tissue engineering. Materials could interfere
with cells adhesion, proliferation, and diﬀerentiation.
Currently,there aretwo common approachestomodify
the materials to improve their biocompatibility, coating
with biocompatible materials, or surface modiﬁcation.
As nearly all interaction between cells and artiﬁcial
surfaces are mediated by a layer of absorbed protein,
many proteins have been coated on the surface of target
materials to promote adhesion, (i.e. ﬁbrinogen, colla-
gen, hyaluronan,...).
13 Protein coated substrates are
provided as a two dimensional substrates. Moreover, it
has been shown that ﬁbroblast attachment, morphol-
ogy, proliferation, and collagen synthesis varied from
differentculturesubstratesandthetypeoftheﬁbroblast
obtained from different organs/tissue.
9
An appropriate scaﬀold for ligament regeneration
must be able to provide mechanical strength to initially
withstand the in vivo force and degrade safely at an
appropriate rate in vivo.
39 In vitro studies, a planar
artiﬁcial substrate (i.e. silicon membrane) is usually
used for growing cells and subjected them to
mechanical loading.
Furnishing scaﬀolds with biochemical factors are
also promising. Many biochemical factors including
growth factors could promote tissue regeneration and/
or healing processes.
13
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1767Growth factors are known to play an important role
in the healing response of connective tissues.
27 Several
reports indicate the signiﬁcance of growth factors in the
intrinsichealing process of injured ligaments.
24,32Many
growth factors affect the tendon and ligament healing
process after injury by stimulating extra-cellular matrix
(ECM) synthesis and cell proliferation.
3,17,21,47 It has
been shown that exogenous Transforming Growth
Factors b1(TGF-b1)increasedthecollagensynthesisof
human anterior cruciate ligament cells and human lig-
amentum ﬂavum.
22,35 Platelet Derived Growth Factor-
AB (PDGF-AB),one ofthe major serum growth factor,
is known to enhance cell proliferation and healing
responses,
26,46 as well as to increase rupture force,
stiffness and breaking energy of the tissue.
31
The deﬁnition of the optimal condition of culture,
such as coating of the substrate, synergistic eﬀect of the
substrate and growth factors are required for ligament
tissue engineering.
In order to deﬁne the optimal concentration of
growth factors and the evolution of cells culture on
silicon membrane, which will be subjected to cyclic
stretch for later mechanical study, the objective of the
present work was to investigate the inﬂuences of indi-
vidual growth factors and substrates on the cell pro-
liferation and ECM synthesis. In this work, we studied
the cell viability, proliferation, collagen production of
ﬁbroblast seeded on the diﬀerent substrates and the
eﬀect of PDGF-AB on the cell proliferation and TGF-
b on the ECM synthesis to allow the optimisation of
culture conditions, which could be used for in vitro
reconstruction of ligament/tendon tissues.
MATERIALS AND METHODS
Cells and Culture Conditions
Human skin ﬁbroblast cell line (CRL-2703) was
purchased from American Type Culture Collection
(ATCC, No. 2584882, Manassas, VA). The cells were
placed in 75 cm
2 plastic culture ﬂask with Dulbecco’s
modiﬁed Eagle’s medium/Nutrient F-12 (GibcoBRL,
Life Technologie, France) containing 10% decomple-
mented foetal bovine serum (FBS) supplemented with
100 U/ml penicillin, 100 lg/ml streptomycin, 4 mM
L-glutamine, 2,5 lg/ml fungizone, 1% non-essential
amino acids (GibcoBRL, Life Technologie, France),
150 lg/ml L-ascorbic acid, 1.5 g/l NaHCO3 (Sigma,
France) and were incubated at 37 C [air (95%)a n d
CO2 (5%)]. The medium was changed every 2 days. At
conﬂuence, cells were detached from the culture ﬂask
with 0.125% trypsin–EDTA mixture (Sigma, France)
for 10 min at 37 C, and then resuspended in complete
medium until conﬂuence.
Substrate Surface Treatment
Transparent, elastic silicon sheet (thickness:
0.0254 cm) (Specialty manufacturing INC, USA) was
punched out into round sheets (diameter: 1.4 cm).
Glass slips (diameter: 1.4 cm) (Polylabo, France) and
silicon sheets were sterilised by overnight immersion
in 75% ethanol aqueous solution, air- dried, then
placed in a 24-well multiwell culture plate, and steri-
lised by 10 min UV irradiation. Gelatin solutions (1%
w/v in distilled water) (Sigma, France) were sterilised
by ﬁltration before use. Cells were seeded into 24
wells culture plates at a density of 310
4 cells/cm
2
on different surface glass slips (control surface), sili-
con sheet, coated or not with gelatin for 24 h at 37 C
to allow cell attachment.
Biochemical Stimuli
The concentrations of growth factors used in this
study included those noted to be eﬀective in previous
studies.
37,42 The concentration range for TGF-b was
0.12–25 ng ml
)1 and from 1 to 100 ng ml
)1 for PDGF-
AB. In our study, ﬁve concentrations of TGF-b1 (0.1,
0.5, 1, 5, 10 ng ml
)1) and four concentrations for
PDGF-AB (1, 5, 10 and 50 ng ml
)1) were used. These
concentrations were added to the cultures in order to
determine their effects on the cell proliferation for
PDGF-AB and collagen production for TGF-b1. Cell
proliferation and collagen synthesis were determined
72 h after the addition of the growth factors. Culture
medium containing 10%FBS without growth factors
was used as control.
Fibroblast Proliferation Experiments
MTT Assay
After 72 h PDGF-AB treatment, MTT 3-[4,5-Dim-
ethylthiazol-2,5-diphenyltetrazolium bromide, blue
Thiazolyl] (Sigma, France) was prepared in PBS at a
ﬁnal concentration of 2 mg/ml. Then 125 ll of the
solution were added to each well containing 500 llo f
DMEM without red phenol. The cells were incubated
for 4 h at 37 C to allow the yellow dye to be trans-
formed into blue formazan crystals by the mitochon-
drial dehydrogenases. The insoluble product was
dissolved by addition of 800 ll of acidiﬁed isopropanol
(0.04 N HCl in isopropanol), and thoroughly mixed to
dissolve the dark blue crystals. The supernatants were
removed, centrifuged, and read within 30 min by using
a Beckman DU-600 spectrophotometer (USA) with a
wavelength of 570 and 700 nm was used as reference
wavelength. The optical density difference OD =
OD570 nm)OD700 nm was estimated.
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After 72 h PDGF-AB treatment, cells were tryp-
sinisation then collected by centrifugation (500g) for
10 min. Cells pellets were washed twice with 2 ml of
PBS. 50 ll of the washed cell suspension (1510
4
cells) were stained according the kit instruction
(Coulter DNA Prep Reagents kit; Beckman-Coulter,
Miami, USA) in order to analyse the cell cycle by ﬂow
cytometry (EPICS XL Coulter; Beckman-Coulter).
Primary histograms were generated by gating the cells
according to the surface and the peak of the ﬂuores-
cence signal in order to avoid taking doublets into
account. These histograms were then submitted to
computerised calculations of the cell cycle by using
polynomial analysis derived from the Dean and Jett
model Multi Cycle AV (Phoenix Flow System, San
Diego, USA). For each testing condition, the per-
centage of cells in each phase was determined. DNA
content was analysed in at least 10
5 nuclei in each
sample.
RNA Isolation and RT-PCR
Total cellular RNA were isolated from ﬁbroblasts
after dissolution in TRIzol reagent (Invitrogen,
France) according to the manufacturer’s instructions.
RNA were extracted using chloroform, then samples
were centrifuged (9500g) for 15 min at 4 C. Isopro-
panol was added to precipitate the RNA and the
samples were centrifuged for 10 min under the same
conditions. The RNA pellet was washed by addition of
1m l o f 7 5 % ethanol and centrifuged at 5600g for
5 min. The pellet was resuspended in 50 ll DEPC-
treated water. The concentrations of RNA were
determined spectrophotometrically at 260 nm and the
purity of RNA were controlled by the ratio DO260 nm/
DO280 nm. The ﬁrst strand cDNA was prepared from
the RNA with reverse transcriptase (kit ThermoScript
RT-PCR System) (BioRad, USA). The cDNA was
ampliﬁed by polymerase chain reaction (Platinum Taq
DNA Polymerase) (Invitrogen, France) using the
primers shown in Table 1. Gel electrophoresis of RT-
PCR products was performed in a 2% agarose (Sigma,
France) run in 0.5 Tris/-boric acid EDTA (TBE)
buffer (Bio-Rad, USA). The gel was stained in a
0.5 lg/ml ethidium bromide solution for 20 min and
the images were obtained using a Bio-Rad GS-2000
Molecular Imaging System. Bands intensities were
evaluated against background quantiﬁed by Quantity
One Image software (Bio-Rad, USA) and normalized
to b-actin.
Immuonoﬂuorescence Labelling
After incubation with TGF-b1, the cells were rinsed
with PBS. The cells were incubated for 45 min with
anti-collagen I (1/50 dilution) or anti-collagen III (1/
100 dilution) rabbit IgG polyclonal (Calbiochem,
France) in DMEM without red phenol (GibcoBRL,
Life Technologie, France) containing 0.5% (w/v) BSA.
The cells were then rinsed thoroughly in DMEM
without red phenol and incubated with the second
antibody, Alexa -488 conjugated goat anti-rabbit IgG
(kex = 488 nm, kem = 515 nm) (1/200 dilution) for
30 min in the dark. After washing with DMEM
without red phenol, the cells were ﬁxed with 1%
para-formaldehyde (Sigma, France) in PBS for 10 min,
and rinsed in PBS. The cells were observed under a
ﬂuorescence confocal microscope (SP2-Leica micro
systems, Germany).
Statistical Analysis
Diﬀerences in cell proliferation and collagen syn-
thesis were analysed by one-way ANOVA analysis to
evaluate diﬀerences between groups with PLSD Fisher
correction (Statview IV
 , Abacus Concepts Inc,
Berkley,CA, USA). A p value less than 0.05 was con-
sidered statistically signiﬁcant. All data were expressed
as the mean±standard deviation (SD).
RESULTS
All the works were realized on three types of sub-
strates (silicon sheet, silicon sheet with 1% gelatin
coating as testing surfaces and glass surface used as a
control).
TABLE 1. Prime sequence for RT-PCR.
MRNA Primer sequence Product size (bp)
Type I collagen 5¢-TCC CCA GCC ACA AAG AGT CTA CA-3¢ 155
5¢-GTG ATT GGT GGG ATG TCT TCG TC-3¢
Type III collagen 5¢-CTG CCA TCC TGA ACT CAA GAG TGG-3¢ 447
5¢-CCA TCC TCC AGA ACT GTG TAG G-3¢
b-actin 5¢-ATC TGG CAC CAC ACC TTC TAC AAT GAG CTG CG-3¢ 838
5¢-CGT CAT ACT CCT GCT TGC TGA TCC ACA TCT GC-3¢
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We studied the eﬀect of PDGF-AB on ﬁbroblast
proliferation according to substrates and PDGF con-
centrations by two diﬀerent and complementary
methods.
MTT Assays
The results of the MTT assay are summarized in
Fig. 1. These results were obtained from ﬁbroblast cul-
tured on different substrates at day 3 in the presence or
absence of four different concentrations of PDGF-AB.
On the glass and gelatin coated silicon sheet cultures,
PDGF-AB induced a dose-dependent increase in the
value of A570. On glass culture, the signiﬁcant increase
was observed in the range of 5–50 ng ml
)1 PDGF-AB
(p<0.01).Onthegelatincoatedsiliconsheetculture,the
signiﬁcant increase was observed in the range of 1–
50 ng ml
)1 PDGF-AB (p<0.01). On the silicon sheet
culture, the values of A570 decrease when the concen-
tration of PDGF-AB was above 5 ng ml
)1.
Nevertheless, we observed a loss of cells on silicon
sheet at 50 ng ml
)1 PDGF-AB.
Cell Cycle Analysis
To conﬁrm the MTT results, we also studied the
eﬀect of PDGF-AB on cell cycle (Figs. 2 and 3). Cell
cycle analysis was performed on day 3 of the culture. It
was observed in the three types of substrates that
PDGF-AB induced a concentration-dependant de-
crease in the percentage of cells in G0/G1 phase and an
increase in S and G2/M phase.
On gelatin coated silicon sheet, the percentage of
cells in S-phase was higher than that without gelatin or
glass (Fig. 3C). Moreover, cells exposed to 10 ng ml
)1
of PDGF-AB had the highest percentage of cells in
G2/M phase (p<0.01).
Eﬀect of TGF-b1 on the Expression of Collagens
Eﬀect of TGF-b1 on Type I and Type III Collagens
zmRNA Expressions
The gene expressions of collagens in cells cultured on
diﬀerent substrates were measured by RT-PCR. RT-
PCR analysis of type I and type III collagen were per-
formed at day 3 in the presence or absence of ﬁve dif-
ferent concentrations of TGF-b1. The RT-PCR results
on human ﬁbroblasts seeded on the three substrates are
showninFig. 4.Thequantitativeresultsconcerningtype
I and type III collagen are summarised in Fig. 5.
The mRNA expression of collagen type I is shown
in Fig. 5a. On the glass culture and gelatin coated sil-
icon sheet cultures, there was no signiﬁcant difference
in the mRNA expression of collagen type I between the
TGF-b1 treated group and the control group. Other-
wise, on the silicon sheet culture, the mRNA expres-
sion of collagen type I increased signiﬁcantly in the
presence of 0.1 ng ml
)1 TGF-b1.
The mRNA expression of collagen type III is shown
in Fig. 5b. On the glass culture, we can see a cyclic
effect of TGF-b1 on the expression of collagen type III
and it reached a maximum response at 10 ng ml
)1
TGF-b. Also, compared to control group, the mRNA
expression of collagen type III was decreased signiﬁ-
cantly at a concentration of 0.5 and 1 ng ml
)1 TGF-b1
(p<0.05).
On the gelatin coated silicon sheet cultures, the
signiﬁcant increase in the mRNA expression of colla-
gen type III was observed by the addition of 0.1 and
10 ng ml
)1 TGF-b1( p<0.05).
On the silicon sheet culture, the mRNA expression
of collagen type III decrease when the concentration of
TGF-b1was above 0.5 ng ml
)1.
Qualitative Expression of Type I and Type III Collagens
In parallel of the RT-PCR experiments, we carried
out some experiments by confocal microscopy to visu-
alise the expression of collagen. The protein expression
of collagen type I and type III of the cells cultured on
glass were revealed by indirect immunoﬂuorescence
staining. As shown in Fig. 6, collagen type I occurred as
spots dispersed around the cells, and collagen type III
was organised as network-like ﬁbre. There is no differ-
ence in the expression of type I collagen with the dif-
ferent concentration of TGF-b1. In contrast, the
expression of type III collagen was increased after the
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FIGURE 1. Dose dependent effect of PDGF-AB on cell pro-
liferation by MTT assays. Cells were treated with different
concentrations of PDGF-AB for 72 h. The metabolic activity of
ﬁbroblast seeded on glass, silicon sheet with or without 1%
gelatin was measured by MTT assays. # p<0.05 versus con-
trol glass, *p<0.05 versus control silicon sheet, ¤ p<0.05
versus control gelatin coated silicon sheet, n = 12.
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FIGURE 2. Cell cycle analysis by ﬂow cytometry. Representative cell cycle histogram of the cells cultured on glass (a), gelatin
coated silicon sheet (b). After 3 days of treatment with PDGF-AB (1, 5, 10, 50 ng ml
)1), cells were recovered and DNA staining with
propidium iodide (IP) was performed. Ten thousand cells were analysed for each sample, n =9 .
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collagens was observed on the other substrates (data not
shown).
DISCUSSION
As cell proliferation and matrix synthesis are
important parameters in tissue engineering, the aim
of this study was to optimise the in vitro culture
conditions on ligament/tendon tissues for future
experiments in bioreactors. The effect of PDGF-AB
and TGF-b1 on the cell proliferation and matrix
synthesis of ﬁbroblast cultured on three different
types of substrates (silicon sheet with or without 1%
gelatin, glass) for 3 days were investigated in this
study. For the tissue regeneration, it is better to use
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FIGURE 3. Effect of different concentrations of PDGF-AB on ﬁbroblast cell cycle regulation. Cells cultured on glass (a), silicon
sheet (b), gelatin coated silicon sheet (c). Cells were subjected to different concentrations of PDGF-AB (1, 5, 10, 50 ng ml
)1). The
percentage of cells in each phase of the cell cycle was analysed by ﬂow cytometry. Results are represented as mean±SD of three
independent experiments for each substrate. p<0.05 versus control, n =9 .
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of the properties of the material on cell behaviour.
However, there are many parameters of the
scaffolds to be considered, such as porosity, pore
size, pore interconnectivity, surface property,
topography and chemical composition. Therefore, in
this study, two-dimensional substrates were used to
investigate the inﬂuence of substrate surface prop-
erty on the proliferation and ECM synthesis of
ﬁbroblast.
Firstly, we used PDGF-AB, which was widely used
as a mitogenic growth factor and as a chemotactic
agent for cells such as ﬁbroblasts.
45 Our experiments
demonstrated that cell proliferation was enhanced by
PDGF-AB. This result was consistent with those of the
previous studies on lung ﬁbroblast,
6,30 canine anterior
cruciate ligament cell,
8 human periodontal ligament
(PDL) cells
36 and human anterior cruciate ligament
cell (ACL).
33 PDGF increased the number of ﬁbro-
blasts available to enter the cell replication cycle by
stimulating termination of the G0 phase of the cell
cycle. The results obtained in this study are similar to
those reported by Letson
27 and Schmidt
46 which
showed that PDGF would be an effective growth fac-
tor that stimulates resting cells to advance from G0 to
G1 of the cell cycle.
Although the addition of PDGF-AB resulted in
signiﬁcant increase in cell proliferation on all the sub-
strates, the highest increase was found on gelatin
coated silicon sheet culture. This result may be
explained by the physical properties of the substrate
surface. High cell proliferation was observed for the
substrates with contact angles of 60–80  as well as on
protein coated culture plates such as gelatin.
18 Park
et al. have demonstrated that mescenchymal stem cells
(MSCs) cultured on collagen I or gelatin coated
membranes expressed similar levels of smooth muscles
(SM) markers.
41 Hori et al. reported that the mor-
phology and the proliferation of MSCs were inﬂuenced
by the type of substrate and culture medium.
18 The use
of gelatin coated silicon sheet as a substrate allows to
enhance the cell adhesion, the differentiation and the
proliferation.
In addition, the higher response was found to
10 ng ml
)1 PDGF on gelatin coated silicon sheet
culture but not to the maximal dose as 50 ng ml
)1
PDGF-AB. This ﬁnding indicates that it exist a dose-
dependant effect of PDGF-AB on cell proliferation in
this culture model and 10 ng ml
)1 PDGF might be the
optimal concentration. Indeed, our result was con-
sisting with the previous experiment which demon-
strated that 10 ng ml
)1 of PDGF promoted ﬁbroblast
attachment to collagen coated plates and prolifera-
tion.
21,36
Secondly, we investigated the eﬀect of TGF-b1o n
collagen synthesis. TGF-b1 is the prototype of a large
family of growth factors regulating cell growth,
development, diﬀerentiation, immune system and tis-
sue repair. On the one hand, TGF-b1 mostly inhibited
the cell growth both in vivo and in vitro.
2 It could
arrests cell cycle progression at a point in late G1
phase.
12,19,43 Furthermore, stimulatory effects of
PDGF-AB have been demonstrated to be blocked by
the presence of TGF-b1.
20,23 On the other hand, it has
been shown that TGF-b regulates production of the
ECM, including collagen, ﬁbronectin and tenas-
cin.
11,16,40,44
Therefore, in the second step of our works, we study
the eﬀect of TGF-b1 on the ECM synthesis. Our data
showed that the exogenous TGF-b1 inﬂuenced the
expression of type I and type III collagen in a
substrate- dependant manner.
In our study, the mRNA expression of collagen type
III was higher than that of collagen type I when the
cells were cultured on glass and gelatin coated silicon
sheet for 72 h. During the early phases of ligament
healing and remodelling more type III collagen is
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FIGURE 4. Effect of different concentrations of TGF-b1o n
the mRNA expression of type I and type III collagen. Repre-
sentative RT-PCR results of human ﬁbroblasts seeded on
glass (a), silicon sheet (b), gelatin coated silicon sheet (c). The
OD of each band was normalised to the values of house-
keeping gene, b-actin. The cells were cultured on different
substrates in the presence of different concentrations of TGF-
b1 (0.1, 0.5, 1, 5, 10 ng ml
)1) for 3 days.
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1,10,49 Therefore the
greater upregulation of type III collagen as compared
to type I collagen is a positive indicator that the cells
are secreting signals for the healing and remodelling
process.
However, on glass, we observed the highest
expression of type III collagen mRNA in the
control group. In the present work, we used culture
medium containing 10% FBS. Although, we did
not add any TGF-b1 in the medium, it seemed that
this increase was due to the presence of growth
factors in the serum and which normally stimulate
protein synthesis and other diﬀerent biological
processes.
Furthermore, we found that TGF-b1 eﬀected the
expression of type I and type III collagen synthesis
by ﬁbroblasts with a dose dependant manner. The
expression of type III collagen mRNA on gelatin
coated silicon sheet was signiﬁcantly increased at 0.1
and 10 ng ml
)1 TGF-b1. The results of this study are
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FAWZI-GRANCHER et al. 1774consistent with the previous work which demon-
strated that 10 ng ml
)1 of TGF-b1 may promote
ﬁbroblast attachment.
21 In 2D cell culture, TGF-b1
has been demonstrated to have a dose-dependent
effect on collagen production.
4,7,28,29,32,34
In summary, our results demonstrated that PDGF-
AB promoted the cell proliferation, which is a basic
step in the process of ligament repair. Our data also
suggest that TGF-b1 is an important cytokine during
the early phases of ligament healing process for its role
in the promotion of extra cellular matrix formation.
These results allowed us to determine the main bio-
chemical conditions of in vitro construction of liga-
ment/tendon tissues.
Our results implied that it is better to use protein-
coating substrate to improve the proliferation and the
synthesis of collagen for later mechanical stretching
study. Further studies are needed to determine the
combination of these two growth factors and their
eﬀect on the biological processes.
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FIGURE 6. Immunoﬂuorescence staining of collagen in monolayer cultures of ﬁbroblast on glass visualised by confocal
microscopy. (A) Type I collagen is identiﬁed on the 3rd day of culture by use of anti collagen type I antibodies. Only spots of this
type of collagen were secreted by the cells (arrowhead). (B) Type III collagen is identiﬁed by use of anti collagen type III antibodies.
It appears like network in the cell (arrow). (objectif 40/NA 0.80, Leica, Germany). Bar 40 lm. (a): Control cell (DMEM + 10%FBS);
(b): Cell treated with 0.5 ng ml
)1 TGF-b1; (c): Cell treated with 10 ng ml
)1 TGF-b1.
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